학술논문

Evidence of impaired carbohydrate assimilation in euthyroid patients with Hashimoto's thyroiditis.
Document Type
Journal Article
Source
European Journal of Clinical Nutrition. Feb2016, Vol. 70 Issue 2, p222-228. 7p. 1 Diagram, 3 Charts, 2 Graphs.
Subject
*BLOOD sugar analysis
*GLUCOSE analysis
*AUTOIMMUNE thyroiditis
*BREATH tests
*CARBOHYDRATE content of food
*FRUCTOSE
*GASTROINTESTINAL diseases
*LACTOSE
*LONGITUDINAL method
*MALABSORPTION syndromes
*QUESTIONNAIRES
*SORBITOL
*SWEETENERS
*CASE-control method
*FOOD diaries
*DISEASE complications
Language
ISSN
0954-3007
Abstract
Background/objectives: Hashimoto's thyroiditis (HT) represents a wide-spread autoimmune disease. In euthyroid patients with HT, an impaired assimilation of common carbohydrates has been observed. Our objectives were to compare the frequency of (1) fructose (FM), lactose (LM) and sorbitol malassimilation (SM), (2) gastrointestinal symptoms (GS) following carbohydrate ingestion and (3) recurrent GS relevant to the participants' daily lives.Subjects/methods: We conducted a prospective case-control study of 45 ambulatory patients with HT and 38 healthy volunteers, matched with regard to age, gender and area of origin. Hydrogen breath tests with fructose, lactose, sorbitol and glucose were performed, the lactose testing additionally comprising measurements of capillary blood glucose (cBG). GS during the tests and recurrent GS concerning the participants' daily lives were assessed. A food-frequency questionnaire was administered.Results: FM was diagnosed in 48.9% of patients compared with 26.3% of the control group (P=0.035). In all, 42.2% of patients with HT and 21.1% of healthy controls showed LM (P=0.04). FM and/or LM was present in 73.3% of the patients and in 42.1% of healthy controls (P=0.004). GS after the ingestion of fructose (P=0.003) or lactose (P=0.025) and recurrent GS were significantly more prevalent in the case group. The consumption of free fructose, lactose or sorbitol did not differ.Conclusions: Carbohydrate malassimilation and gastrointestinal complaints are frequent in euthyroid patients with HT, leading to novel clinical and pathophysiological considerations and concepts. [ABSTRACT FROM AUTHOR]